Document Type : Letter to the Editor
Authors
1 Department of Clinical Pharmacy, School of Pharmacy, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3 School of Medicine, Semmelweis University, Budapest, Hungary
4 Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran Division of Critical Care Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
Abstract
-
Keywords
Main Subjects
- Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325(21): 1468-75.
- Baang HY, Reynolds AS, Dangayach NS, Gilmore EJ, Kim JA, Lay C. Treatment Effect of Early Intravenous Milrinone for Cerebral Vasospasm or Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care 2025; 43(1): 19-26.
- Fraticelli AT, Cholley BP, Losser MR, Maurice JPS, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2008; 39(3): 893-8.
- Santos-Teles AG, Ramalho C, Ramos JGR, Passos Rd, Gobatto A, Farias S, et al. Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: A systematic review. Rev Bras Ter Intensiva 2020; 32(4): 592-602.
- Julian N, Gaugain S, Labeyrie MA, Barthélémy R, Froelich S, Houdart E, et al. Systemic tolerance of intravenous milrinone administration for cerebral vasospasm secondary to non-traumatic subarachnoid hemorrhage. J Crit Care 2024; 82: 154807.
- Ribeiro E, Vale N. Repurposing Terbutaline and Milrinone for Cancer Therapy: A Comprehensive Review. Future Pharmacology 2025; 5(3): 38.
- Sezer C, Zırh S, Gokten M, Sezer A, Acıkalın R, Bilgin E, et al. Neuroprotective Effects of Milrinone on Acute Traumatic Brain Injury. World Neurosurg 2023; 170: e558-e567.
- Szabo V, Baccialone S, Kucharczak F, Dargazanli C, Garnier O, Pavillard F, et al.CT perfusion-guided administration of IV milrinone is associated with a reduction in delayed cerebral infarction after subarachnoid hemorrhage. Sci Rep 2024; 14(1): 14856.
- Arac D, Erdi MF, Keskin F, Kenan M, Cuce G, Aydemir FHY, et al. Neuroprotective Effects of Milrinone on Experimental Acute Spinal Cord Injury: Rat Model. World Neurosurg 2021; 147: e225-e233.
- Raupach A, Reinle J, Stroethoff M, Mathes A, Heinen A, Hollmann MW, et al. Milrinone-Induced Pharmacological Preconditioning in Cardioprotection: Hints for a Role of Mitochondrial Mechanisms. J Clin Med 2019; 8(4): 507.
- Uysal E, Dokur M, Altınay S, Saygili EI, Batcıoglu K, Ceylan MS, et al. Investigation of the Effect of Milrinone on Renal Damage in an Experimental Non-Heart Beating Donor Model. Journal of Investigative Surgery 2018; 31(5): 402-11.
- Bernier TD, Schontz MJ, Izzy S, Chung DY, Nelson SE, Leslie-Mazwi TM, et al., Treatment of Subarachnoid Hemorrhage-associated Delayed Cerebral Ischemia With Milrinone: A Review and Proposal. J Neurosurg Anesthesiol 2021; 33(3): 195-202.
)